Research advances on L-DOPA-induced dyskinesia: from animal models to human disease

X Chen, Y Wang, H Wu, C Cheng, W Le - Neurological Sciences, 2020 - Springer
Abstract L-3, 4-dihydroxyphenylalanine (L-DOPA) was introduced about half a century ago
and is still the most effective medicine for the treatment of Parkinson's disease (PD) …

Research advances on L-DOPA-induced dyskinesia: from animal models to human disease

X Chen, Y Wang, H Wu, C Cheng… - Neurological …, 2020 - search.proquest.com
Abstract L-3, 4-dihydroxyphenylalanine (L-DOPA) was introduced about half a century ago
and is still the most effective medicine for the treatment of Parkinson's disease (PD) …

Research advances on L-DOPA-induced dyskinesia: From animal models to human disease.

X Chen, Y Wang, H Wu, C Cheng, W Le - Neurological Sciences, 2020 - psycnet.apa.org
Abstract L-3, 4-dihydroxyphenylalanine (L-DOPA) was introduced about half a century ago
and is still the most effective medicine for the treatment of Parkinson's disease (PD) …

Research advances on L-DOPA-induced dyskinesia: from animal models to human disease.

X Chen, Y Wang, H Wu, C Cheng… - … and of the Italian Society of …, 2020 - europepmc.org
L-3, 4-dihydroxyphenylalanine (L-DOPA) was introduced about half a century ago and is still
the most effective medicine for the treatment of Parkinson's disease (PD). However, such …

Research advances on L-DOPA-induced dyskinesia: from animal models to human disease

X Chen, Y Wang, H Wu… - … : official journal of the …, 2020 - pubmed.ncbi.nlm.nih.gov
L-3, 4-dihydroxyphenylalanine (L-DOPA) was introduced about half a century ago and is still
the most effective medicine for the treatment of Parkinson's disease (PD). However, such …

Research advances on L-DOPA-induced dyskinesia: from animal models to human disease.

X Chen, Y Wang, H Wu, C Cheng… - Neurological …, 2020 - search.ebscohost.com
Abstract L-3, 4-dihydroxyphenylalanine (L-DOPA) was introduced about half a century ago
and is still the most effective medicine for the treatment of Parkinson's disease (PD) …